PriceTargets.com logo

NASDAQ:HAPP - Happiness Biotech Group Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.67 As of 12/8/2021 01:00 AM ET
▲ +0.03 (4.72%)

This chart shows the closing price for HAPP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Happiness Biotech Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HAPP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HAPP

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Happiness Biotech Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.67.

This chart shows the closing price for HAPP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Happiness Biotech Group. This rating has held steady since November 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/17/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/15/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/14/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/6/2019AegisInitiated CoverageBuyLow
(Data available from 12/9/2016 forward)

News Sentiment Rating

1.60 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/13/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/12/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/12/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/11/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/10/2021
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/10/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/9/2021
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/9/2021

Current Sentiment

  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Happiness Biotech Group logo
Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powder, cordyceps mycelia, ejiao solution, American ginseng, and other products. It also offers a range of ganoderma lucidum products, such as essence oil, cleansing milk, shampoo, shower gel, and nourishing cream products under the Cai Zhi Ning brand, as well as edible fungi. In addition, the company provides disinfectants, non-medical face masks, and COVID-19 anti-body testing kits. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. Happiness Biotech Group Limited was founded in 2004 and is headquartered in Nanping, the People's Republic of China.
Read More

Today's Range

Now: $0.67
Low: $0.63
High: $0.67

50 Day Range

MA: $0.86
Low: $0.63
High: $1.08

52 Week Range

Now: $0.67
Low: $0.61
High: $2.58

Volume

98,146 shs

Average Volume

677,451 shs

Market Capitalization

$21.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Frequently Asked Questions

What sell-side analysts currently cover shares of Happiness Biotech Group?

The following sell-side analysts have issued research reports on Happiness Biotech Group in the last twelve months: Zacks Investment Research.
View the latest analyst ratings for HAPP.

What is the current price target for Happiness Biotech Group?

0 Wall Street analysts have set twelve-month price targets for Happiness Biotech Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Happiness Biotech Group in the next year.
View the latest price targets for HAPP.

What is the current consensus analyst rating for Happiness Biotech Group?

Happiness Biotech Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for HAPP.

What other companies compete with Happiness Biotech Group?

Other companies that are similar to Happiness Biotech Group include Natural Alternatives International, Mannatech, Grove, FitLife Brands, MediWound, Bon Natural Life, Charlie's, Charlie's, Glucose Health, General Cannabis, Tauriga Sciences, Nutra Pharma, GLG Life Tech, TBG Diagnostics and Heyu Biological Technology.

How do I contact Happiness Biotech Group's investor relations team?

Happiness Biotech Group's physical mailing address is NO. 11 DONGJIAO EAST ROAD SHUANGXI SHUNCHANG, NANPING F4, 353001. The company's listed phone number is 86-059-9782-8808 and its investor relations email address is [email protected] The official website for Happiness Biotech Group is www.happ.org.cn.